1 / 13

Overview of Reverse Sequence Syphilis Testing

Overview of Reverse Sequence Syphilis Testing. Presented May 2012 at Oregon Epidemiologist Conference by Doug Harger, Manager, STD Prevention and Control Program, HIV/STD/TB Program, Center for Public Health Practice, Oregon Health Division 971-673-0181; douglas.r.harger@state.or.us

oakley
Download Presentation

Overview of Reverse Sequence Syphilis Testing

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Overview of Reverse Sequence Syphilis Testing • Presented May 2012 at Oregon Epidemiologist Conference by Doug Harger, Manager, STD Prevention and Control Program, HIV/STD/TB Program, Center for Public Health Practice, Oregon Health Division • 971-673-0181; douglas.r.harger@state.or.us • Modifed July 23, 2012

  2. Syphilis Testing: Something New? There are 2 classes of blood test for syphilis

  3. Syphilis Testing: Something New? • (1) non-treponemal, cardiolipin antibody tests—used for screening asymptomatic people and assessing response to treatment • Rapid Plasma Reagin (RPR) • Venereal Disease Research Laboratory test (VDRL)

  4. Syphilis Testing: Something New? • (2) Treponemal tests—in US generally used as confirmatory tests but EIA and CIA sometimes used for screening. • Fluorescent treponemal antibody absorbtion test (FTA-ABS) • TreponemaPallidum-Particle Agglutination Test (TP-PA) • MicrohemaglutinationTreponemaPallidum (MHA-TP) • Enzyme Immunoassay (EIA) • Chemiluminescent Immunoassay (CIA) ,

  5. Syphilis Testing Points If an individual has newly acquired syphilis, a treponemal test generally is positive before the non-treponemal test. Example: a person has a primary syphilitic lesion for 5 days – the FTA may be reactive and the RPR non reactive.

  6. Traditional Sequence Testing non-treponemal test first, e.g., RPR, if non-reactive, generally no further testing; If RPR is reactive, the specimen is reflexed for a treponemal test, e.g., FTA, TP-PA.

  7. Reverse Sequence Syphilis Testing • Testing serum for syphilis first with a confirmatory test, generally a treponemal EIA (enzyme immunoassay), or chemiluminescence immunoassay (CIA). • If the treponemal EIA result is non-reactive the result is reported as negative – no further testing generally recommended.

  8. Reverse Sequence Syphilis Testing If the treponemal EIA or CIA is reactive, the specimen is reflexed for an RPR. If the RPR is reactive, the interpretation is past or present syphilis infection. If no treatment history—treat

  9. Reverse Sequence Syphilis Testing If the RPR is non-reactive after a positive EIA or CIA, the specimen should be tested reflexively with another treponeme specific test, ideally TP-PA. If the TP-PA is non-reactive, the EIA is likely a false positive. If the TP-PA is reactive, likely represents and old infection, or possibly a very new infection.

  10. Why Switch to EIA/CIA? Automated Lower costs No false negatives due to prozone reaction Objective results May be useful for dx of early primary syphilis—positive earlier in infection than non-treponemal tests

  11. Limitations of EIA/CIA Cannot distinguish between new/active disease & old disease - treated or untreated. Confusion about management of patients with discrepant serology – positive EIA/CIA and a negative RPR

  12. Recent Examples Patient presents with a rash, EIA is highly reactive > 8.0, reflexed RPR is 1:128; patient is treated as secondary syphilis. Routine draw on a patient, EIA is reactive, reflexed RPR is non-reactive, TP-PA is non-reactive, the EIA result is considered false positive, patient not infected.

  13. CDC Recommendations “CDC continues to recommend the traditional syphilis screening algorithm …, however, if reverse sequence screening is used, reactive sera by a treponemal test should be tested reflexively with a quantitative non-treponemal test.” For example, a RPR.

More Related